Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Drug Metabolism Letters|March 18, 2014
Culture duration-, donor-, and medium-dependent changes in OATP1B3-mediated telmisartan uptake in human hepatocytesQing Zhu, Haiyan Xia, Cindy Q Xia, et al.
The Journal of Pharmacy and Pharmacology|November 8, 2003
Effect of bupropion on CYP2B6 and CYP3A4 catalytic activity, immunoreactive protein and mRNA levels in primary human hepatocytes: comparison with rifampicinLeah M Hesse, Yumiko Sakai, Daesety Vishnuvardhan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 15, 2018
Cryopreserved Human Intestinal Mucosal Epithelium: A Novel In Vitro Experimental System for the Evaluation of Enteric Drug Metabolism, Cytochrome P450 Induction, and EnterotoxicityAlbert P Li, Novera Alam, Kirsten Amaral, et al.
Chemico-Biological Interactions|October 26, 2002
Correlation between troglitazone cytotoxicity and drug metabolic enzyme activities in cryopreserved human hepatocytesNicola J Hewitt, Scott Lloyd, Mike Hayden, et al.
Chemico-Biological Interactions|October 26, 2002
Identification of glutathione conjugates of troglitazone in human hepatocytesSaileta Prabhu, Andrew Fackett, Scott Lloyd, et al.
Biochemical Pharmacology|July 21, 2018
Strategies and limitations associated with in vitro characterization of vitamin D receptor activatorsPaola Bukuroshi, Hiroshi Saitoh, Lilia Magomedova, et al.
Chemico-Biological Interactions|October 26, 2002
Differential in vitro hepatotoxicity of troglitazone and rosiglitazone among cryopreserved human hepatocytes from 37 donorsScott Lloyd, Michael J Hayden, Yumiko Sakai, et al.
Molecular Pharmaceutics|April 12, 2022
Prediction of In Vivo Pharmacokinetic Parameters and Time-Exposure Curves in Rats Using Machine Learning from the Chemical StructureOlga Obrezanova, Anton Martinsson, Tom Whitehead, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 23, 2018
Comparison of uptake transporter functions in hepatocytes in different species to determine the optimal model for evaluating drug transporter activities in humansMingxiang Liao, Qing Zhu, Andy Zhu, et al.
Pageof 9